Tracking a new imaging test for pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a new imaging procedure called LINFU® that may help doctors better detect pancreatic cancer. You may join if you have symptoms or an abnormal scan that suggests pancreatic cancer, and you're scheduled for a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- You have symptoms that might be from pancreatic cancer, such as jaundice, stomach pain, weight loss, or new diabetes, OR a recent scan suggests pancreatic cancer.
- You are able to have an endoscopy (EUS or ERCP) and receive contrast dye and/or secretin.
- You are not pregnant and can provide informed consent.
- You do not have a known allergy to the contrast agent or secretin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is studying a new screening method (LINFU®) to find pancreatic cancer early in people who have no symptoms or known risk factors, to see if it can help detect cancer in the general population.
This study looks at MRI scans, computer-extracted imaging features, and blood/“liquid biopsy” tests after FOLFIRINOX chemotherapy to predict whether surgery can fully remove pancreatic cancer. It may help your care team choose the best next step—whether surgery is likely to be possible and how to plan it.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This study checks how well the LUM Imaging System can detect cancers of the esophagus, colon, or pancreas during the time you are preparing for surgery. It’s mainly meant to see if the scan works safely and clearly for doctors to find cancer areas.
This trial tests a new ultrasound treatment called Suizenji for people with pancreatic cancer that cannot be removed by surgery. The goal is to see if it can safely target the tumor.
This study tests new ultrasound methods to better see the pancreas and thyroid. It includes people at high risk for pancreatic cancer, those with pancreatic cancer, those with a thyroid nodule, and healthy volunteers.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.